Literature DB >> 9830056

Nitric oxide and N-acetylcysteine inhibit the activation of mitogen-activated protein kinases by angiotensin II in rat cardiac fibroblasts.

D Wang1, X Yu, P Brecher.   

Abstract

Angiotensin II acts on the cardiac fibroblast to produce a mitogenic response. Nitric oxide and N-acetylcysteine have been used to determine if oxidative stress influenced the effects of angiotensin II on the cardiac fibroblast. Angiotensin II activated the mitogen-activated protein kinases designated extracellular signal-regulated kinases within 5 min by interacting with the AT1 receptor. This activation was completely independent of protein kinase C and was inhibited when farnesylation was blocked, implicating Ras involvement. Pretreatment of cardiac fibroblasts with either N-acetylcysteine for 8 h or nitric oxide for 10 min suppressed this activation by angiotensin II in a dose-dependent manner. However, when both agents were added, inhibition was essentially complete. This combined effect of N-acetylcysteine and nitric oxide to block ERKs activation also was found if the activity was stimulated by either another growth factor (platelet-derived growth factor) or by the addition of phorbol ester, suggesting the effect was not limited to the receptor site alone. The results are consistent with the hypothesis that hormonal activation of mitogenic steps such as ERKs is influenced by increased oxidative stress, which is reduced by the combined effects of N-acetylcysteine and nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9830056     DOI: 10.1074/jbc.273.49.33027

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Analysis of S-nitroso-N-acetylpenicillamine effects on dopamine release in the striatum of freely moving rats: role of endogenous ascorbic acid and oxidative stress.

Authors:  P A Serra; G Esposito; M R Delogu; R Migheli; G Rocchitta; E Miele; M S Desole; M Miele
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

2.  Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation.

Authors:  H S Park; S H Huh; M S Kim; S H Lee; E J Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

3.  Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.

Authors:  Jin Ye; Chunfu Wang; Rhea Sumpter; Michael S Brown; Joseph L Goldstein; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

4.  Dual role of nNOS in ischemic injury and preconditioning.

Authors:  Anupama Barua; Nicholas B Standen; Manuel Galiñanes
Journal:  BMC Physiol       Date:  2010-08-13

5.  Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration.

Authors:  Hiroyuki Suzuki; Keita Kimura; Heigoro Shirai; Kunie Eguchi; Sadaharu Higuchi; Akinari Hinoki; Kazuhiro Ishimaru; Eugen Brailoiu; Danny N Dhanasekaran; Laura N Stemmle; Timothy A Fields; Gerald D Frank; Michael V Autieri; Satoru Eguchi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-18       Impact factor: 8.311

6.  The PKC and ERK/MAPK pathways regulate glucocorticoid action on TRH transcription.

Authors:  Antonieta Cote-Vélez; Leonor Pérez-Martínez; Jean-Louis Charli; Patricia Joseph-Bravo
Journal:  Neurochem Res       Date:  2008-04-22       Impact factor: 3.996

7.  Potentiation of protein kinase C zeta activity by 15-deoxy-delta(12,14)-prostaglandin J(2) induces an imbalance between mitogen-activated protein kinases and NF-kappa B that promotes apoptosis in macrophages.

Authors:  Antonio Castrillo; Paqui G Través; Paloma Martín-Sanz; Scott Parkinson; Peter J Parker; Lisardo Boscá
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

8.  Angiotensin II dose-dependently stimulates human renal proximal tubule transport by the nitric oxide/guanosine 3',5'-cyclic monophosphate pathway.

Authors:  Ayumi Shirai; Osamu Yamazaki; Shoko Horita; Motonobu Nakamura; Nobuhiko Satoh; Hideomi Yamada; Masashi Suzuki; Akihiko Kudo; Hayato Kawakami; Franz Hofmann; Akira Nishiyama; Haruki Kume; Yutaka Enomoto; Yukio Homma; George Seki
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

9.  The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis.

Authors:  Wei Qu; Jie Liu; Richard Fuquay; Joseph E Saavedra; Larry K Keefer; Michael P Waalkes
Journal:  Cancer Lett       Date:  2007-07-20       Impact factor: 8.679

10.  V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity.

Authors:  Wei Qu; Jie Liu; Anna L Dill; Joseph E Saavedra; Larry K Keefer; Michael P Waalkes
Journal:  Cancer Sci       Date:  2008-12-15       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.